Comorbid OCD Confers Greater Neurocognitive Impairment in Schizophrenia

Share this content:
Approximately 30% of patients with schizophrenia have OCD, which can further impair social and cognitive functioning.
Approximately 30% of patients with schizophrenia have OCD, which can further impair social and cognitive functioning.

Patients with schizophrenia who have comorbid obsessive compulsive disorder (OCD) experience greater neurocognitive impairment than patients with schizophrenia who do not have OCD, according to the results of a study published in Schizophrenia Research.

Schizophrenia is frequently accompanied by comorbid psychiatric disorders. Approximately 30% of patients with schizophrenia have OCD, which can further impair social and cognitive functioning. Efforts to cognitively differentiate between patients with and without schizophrenia and OCD have yielded conflicting results, however.

Swapnajeet Sahoo, MD, of the Department of Psychiatry at the Postgraduate Institute of Medical Education & Research in Chandigarh, India, and colleagues evaluated 40 patients with schizophrenia and comorbid OCD and compared them with 39 patients with schizophrenia but without OCD. Patients were assessed with the Trail Making Test A and B (TMT-A/B), Controlled Oral Word Association (COWA) test, Stroop test, Tower of London (TOL) test, and Positive and Negative Syndrome Scale (PANSS) test. Severity of OCD was evaluated with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).

In the patients with OCD, 26 had the disorder as an inherent part of their illness while 14 patients had developed OCD after starting antipsychotic medication. Most patients in both groups had paranoid type schizophrenia.

Patients with comorbid OCD had more severe cognitive deficits than patients without. Effect sizes were medium to large. In particular, the investigators observed significant differences in the domains of processing speed (TMT-A, P =.018), verbal fluency (COWA, P <.001), cognitive flexibility (TMT-B, P =.006), and executive functioning (TOL-2 moves, 3 moves, and 4 moves problems). In patients with OCD, the researchers found significant associations in Y-BOCS total score with verbal fluency (perseveration words, P =.006; variant words, P =.036), cognitive processing and selective attention (Stroop score, P =.04), and executive functioning, although significance was found for 2-moves problems only.

The investigators noted that the results of this study demonstrate that patients with schizophrenia and comorbid OCD have diminished processing speed, poor verbal fluency, low cognitive flexibility, and poor executive functioning compared with patients with schizophrenia without OCD.

Among the study limitations are the fact that all patients were receiving antipsychotics, which may have affected cognitive functioning; assessments were done cross-sectionally; intelligence quotient (IQ) was not assessed in the study; and that the sample size was relatively small.

The researchers concluded that in considering patients with schizophrenia for cognitive remediation, comorbid OCD must be taken into account as patients with both disorders have a poorer neurocognitive profile.

Reference

Sahoo S, Grover S, Nehra R. Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder [published online May 29, 2018]. Schizophr Res. doi:10.1016/jschres.2018.05.029

You must be a registered member of Psychiatry Advisor to post a comment.

Sign Up for Free e-newsletters